Disease | glutaryl-coa dehydrogenase deficiency |
Comorbidity | C0031511|pheochromocytoma |
Sentences | 1 |
PubMedID- 25894842 | [46] first measured the circulating cga in a patient with pheochromocytoma by the immunoassay method and demonstrated that cga might be a potential biomarker of this tumor, many studies have evaluated its clinical impact in various neuroendocrine tumors [16–18, 47–49]. |
Page: 1